Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T20:10:20.817Z.
Consensus retrieved: 2026-10-06T08:21:14.144Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T20:10:20.817Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f1b69e3b66f27443032d61e4b8b82fea4bf8ea9e73a5af38069dd33813f2151d
FORWARD PE RATIO
N/A
AC Immune S.A.
Market Cap
$256.47M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| AC Immune S.A. (ACIU) | $256.47M | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 18.21 |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | N/A |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | N/A |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in CHF, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
